SCHEMBL16328346

SCHEMBL16328346

OC(CF)(c1ccc(Br)cc1)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ NR1H2 P55055 4/20 0.33
▸ NR1H3 Q13133 4/20 0.33
▸ KCNJ11 Q14654 1/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ AR P10275 2/20 0.33
▸ S1PR4 O95977 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ S1PR1 P21453 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ OGG1 O15527 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ HSD11B1 P28845 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17026 0.83 AR (0.46) CA1CA2CA5ACA9NR1H2
SCHEMBL4987167 0.82 AR (0.47) CA1CA2CA5ACA9NR1H2
SCHEMBL18065574 0.82 AR (0.47) CA1CA2CA5ACA9NR1H2
SCHEMBL18595674 0.81 TRPV1 (0.37) NR1H2NR1H3KCNJ11ARS1PR4
SCHEMBL16098862 0.77 NR1H2 (0.38) CA1CA2CA5ACA9NR1H2
SCHEMBL15462891 0.76 MGLL (0.55) CA1CA2CA5A
SCHEMBL17278184 0.75 ALDH1A1 (0.41) NR1H2NR1H3ARS1PR4ALDH1A1
SCHEMBL15974610 0.73 CA1 (0.43) CA1CA2CA5ACA9CYP2A6
SCHEMBL17054 0.73 NR1H2 (0.56) CA1CA2CA5ACA9NR1H2
SCHEMBL18095732 0.72 LMNA (0.38) CA1CA2CA5ACA9KCNJ11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150065500-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-03-05 — — US disclosed
US-8324207-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-12-04 — — US disclosed
US-20110172229-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150065500-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 CA1 4884/4885CA2 2789/4885CA5A 1711/4885
US-20110172229-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 CA1 4884/4885CA2 2789/4885CA5A 1711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback